Davis's Drug Guide
Update Information
Latest Update
This resource was last updated on: 2024-4-18
New topics:
- abrocitinib
- adapalene
- afamelanotide
- anacaulase
- andexanet alfa
- angiotensin II
- atogepant
- clascoterone
- defibrotide
- deucravacitinib
- emapalumab
- fezolinetant
- fostamatinib
- fostemsavir
- halobetasol/tazarotene
- inclisiran
- inebilizumab
- lecanemab
- levodopa
- molnupiravir
- nirmatrelvir/ritonavir
- opicapone
- ozenoxacin
- patisiran
- prabotulinumtoxina
- relugolix/estradiol/norethindrone
- rifamycin
- ritlecitinib
- ruxolitinib (topical)
- sodium phenylbutyrate/taurursodiol
- sulbactam/durlobactam
- trifarotene
- turmeric
- voclosporin
- zavegepant
- zuranolone
Citation
Vallerand, April Hazard., et al. "Update Information." Davis's Drug Guide, 18th ed., F.A. Davis Company, 2023. Medicine Central, im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/50998/all/___Update_Information___.
Vallerand AHA, Sanoski CAC, Quiring CC. Update Information. Davis's Drug Guide. F.A. Davis Company; 2023. https://im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/50998/all/___Update_Information___. Accessed April 18, 2024.
Vallerand, A. H., Sanoski, C. A., & Quiring, C. (2023). Update Information. In Davis's Drug Guide (18th ed.). F.A. Davis Company. https://im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/50998/all/___Update_Information___
Vallerand AHA, Sanoski CAC, Quiring CC. Update Information [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2023. [cited 2024 April 18]. Available from: https://im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/50998/all/___Update_Information___.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Update Information
ID - 50998
A1 - Sanoski,Cynthia A,
AU - Vallerand,April Hazard,
AU - Quiring,Courtney,
BT - Davis's Drug Guide
UR - https://im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/50998/all/___Update_Information___
PB - F.A. Davis Company
ET - 18
DB - Medicine Central
DP - Unbound Medicine
ER -
